Detalhe da pesquisa
1.
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics.
Lipids Health Dis
; 23(1): 95, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566209
2.
The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study.
BMC Med
; 20(1): 414, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307799
3.
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease.
Diabetes Metab Res Rev
; 38(8): e3570, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938229
4.
Diagnosis and genetic analysis of a case with Bardet-Biedl syndrome caused by compound heterozygous mutations in the BBS12 gene.
Yi Chuan
; 44(10): 975-982, 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384733
5.
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.
J Lipid Res
; 62: 100031, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859645
6.
Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes.
J Transl Med
; 19(1): 393, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34530846
7.
Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients.
BMC Endocr Disord
; 21(1): 27, 2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602203
8.
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
Lipids Health Dis
; 20(1): 126, 2021 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602072
9.
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease.
Lipids Health Dis
; 20(1): 27, 2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757528
10.
Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes.
Diabetes Metab Res Rev
; 36(5): e3292, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955491
11.
DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population.
Biomed Eng Online
; 19(1): 78, 2020 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054764
12.
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Endocr Pract
; 26(4): 444-453, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31968197
13.
The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Diabetologia
; 62(4): 644-654, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30673802
14.
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.
Diabetes Obes Metab
; 26(2): 772-776, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975640
15.
FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Lipids Health Dis
; 18(1): 197, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729980
16.
Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: A prospective cohort study.
Diabetes Metab Res Rev
; 34(7): e3048, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035847
17.
Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.
Lipids Health Dis
; 17(1): 114, 2018 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759071
18.
Optimal Vitamin D Status in a Middle-Aged and Elderly Population Residing in Shanghai, China.
Med Sci Monit
; 23: 6001-6011, 2017 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29255137
19.
Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling.
J Hepatol
; 74(4): 974-977, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340578
20.
Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.
J Transl Med
; 14: 266, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629750